The role of G-CSF in the treatment of advanced tumors

被引：6

作者：

Bottoni, Ugo ^{[1
]}

Trapasso, Francesco ^{[1
]}

机构：

[1] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, I-88100 Catanzaro, Italy

来源：

CANCER BIOLOGY & THERAPY | 2009年 / 8卷 / 18期

关键词：

G-CSF; metastasis; anticancer therapy; COLONY-STIMULATING FACTOR; ADJUVANT THERAPY; BRAIN-METASTASES; CANCER; MELANOMA; SUPPORT; GROWTH; PLUS; ANGIOGENESIS; SARGRAMOSTIM;

D O I：

10.4161/cbt.8.18.9453

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1744 / 1746

页数：3

共 27 条

[1] Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice [J].

Battiwalla, M. ;

McCarthy, P. L. .

BONE MARROW TRANSPLANTATION, 2009, 43 (05) :351-356

[2] Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF [J].

Bottoni, U ;

Bonaccorsi, P ;

Devirgiliis, V ;

Panasiti, V ;

Borroni, RG ;

Trasimeni, G ;

Clerico, R ;

Calvieri, S .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (09) :507-513

[3] Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of baldder cancer cells [J].

Chakraborty, Arup ;

Guha, Sushovan .

UROLOGY, 2007, 69 (06) :1210-1215

[4] Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine plus FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 trial) [J].

Correale, Pierpaolo ;

Tagliaferri, Pierosandro ;

Fioravanti, Antonella ;

Del Vecchio, Maria Teresa ;

Remondo, Cinzia ;

Montagnani, Francesco ;

Rotundo, Maria Saveria ;

Ginanneschi, Chiara ;

Martellucci, Ignazio ;

Francini, Edoardo ;

Cusi, Maria Grazia ;

Tassone, Pierfrancesco ;

Francini, Guido .

CLINICAL CANCER RESEARCH, 2008, 14 (13) :4192-4199

[5] Second-line treatment of non-small cell lung cancer by biweekly gemcitabine and docetaxel plus /- granulocyte-macrophage colony stimulating factor and low dose aldesleukine [J].

Correale, Pierpaolo ;

Miano, Salvatora Tindara ;

Remondo, Cinzia ;

Migali, Cristina ;

Rotundo, Maria Saveria ;

Macri, Paolo ;

Tagliaferri, Pierosandro ;

Tassone, Pierfrancesco ;

Caraglia, Michele ;

Gotti, Giuseppe ;

Francini, Guido .

CANCER BIOLOGY & THERAPY, 2009, 8 (06) :497-502

[6] Sequential administration of GM-CSF (Sargramostim®) and IL-2 ± autologous vaccine as adjuvant therapy in cutaneous melanoma:: An interim report of a phase II clinical trial [J].

Elias, E. George ;

Zapas, John L. ;

McCarron, Edward C. ;

Beam, Sandra L. ;

Hasskamp, Joanne H. ;

Culpepper, W. Joel .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (03) :285-291

[7] Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer [J].

Fujita, A ;

Fukuoka, S ;

Takabatake, H ;

Tagaki, S ;

Sekine, K .

ONCOLOGY, 2000, 59 (04) :291-295

[8] Biochemotherapy in the treatment of metastatic melanoma in selected patients [J].

Gonzalez Astorga, Beatriz ;

Jimenez Rubiano, Berta ;

Delgado Perez, Juan Ramon ;

Valdivia Bautista, Javier ;

Sanchez Toro, Carmen ;

Gonzalez Flores, Encarnacion ;

Luque Caro, Raquel ;

Castellon Rubio, Victoria .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (06) :382-386

[9] Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy [J].

Herbst, Christine ;

Naumann, Frauke ;

Kruse, Eva-Brigitta ;

Monsef, Ina ;

Bohlius, Julia ;

Schulz, Holger ;

Engert, Andreas .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01)

[10]

Kidd PM, 2009, ALTERN MED REV, V14, P14

← 1 2 3 →